Product Introduction
Nevimune Oral Suspension combines Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), and Lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI), to suppress HIV replication and improve immune function in children.
Uses
-
Treatment of HIV-1 infection in pediatric patients
-
Used as part of combination antiretroviral therapy (ART)
Benefits
-
Suppresses HIV viral load
-
Helps increase CD4 cell count
-
Improves immune system function
-
Oral suspension form is easy for children to take
Composition
Per 5 ml suspension contains:
-
Nevirapine 50 mg
-
Lamivudine 5 mg
Side Effects
Common side effects:
-
Rash
-
Fever
-
Headache
-
Nausea
-
Diarrhea
-
Liver enzyme abnormalities
Serious side effects require immediate medical attention.
Safety Advice
-
Follow prescribed dosing strictly
-
Monitor liver function regularly
-
Inform doctor about any allergic reactions or liver disease
-
Store in a cool, dry place and shake well before use
-
Keep out of reach of children
